文献速递乳腺病理

乳腺交界性病变分类局限:英国国家乳腺筛查EQA方案洞察

Borderline breast lesions and the limits of classification: insights from the UK National Breast Screening EQA scheme.
PubMed 文献 · Histopathology · 2026-05-21

该研究分析2015至2025年间UK NHS乳腺筛查EQA方案中263例连续病例,发现整体诊断一致性高(67.4%参与者全病例100%一致),但15例(5.7%)未达协调者≥80%一致阈值,平均一致率57%,主要涉及非典型上皮增生和乳头状病变的诊断阈值挑战。

要点

  • 67.4%参与者在所有 circulated 病例中达到100%诊断一致。
  • 15例(5.7%)未达协调者≥80%一致阈值,平均一致率57%。
  • 不一致病例主要涉及非典型上皮增生和乳头状病变。

核心结论

  • 整体一致性高,但少数生物学交界性病变仍产生显著诊断变异,支持细化诊断标准和针对性教育策略。

研究设计与样本

  • 回顾性分析2015至2025年间UK NHS乳腺筛查EQA方案中263例连续病例,每例由最多22名协调者和平均678名参与者评估。

主要发现

  • 67.4%参与者在所有 circulated 病例中达到100%一致。
  • 15例(5.7%)未达协调者≥80%一致阈值,协调者平均一致率57%(范围25%-79%),参与者范围25%-87%。
  • 不一致病例主要涉及非典型上皮增生和乳头状病变,尤其是诊断阈值之间的病变。

关键数值与推荐

  • 协调者一致率<80%的病例被详细分析。
  • 持续挑战包括区分小叶肿瘤亚型、大汗腺非典型、平坦上皮非典型及相关病变,以及原位与浸润性乳头状癌。

临床怎么用

  • 病理医生应关注乳腺交界性病变的诊断阈值,尤其是非典型上皮增生和乳头状病变,以提高诊断可重复性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Previous concordance studies in breast pathology have demonstrated high levels of diagnostic agreement. This study aimed to characterize breast lesions associated with the lowest levels of concordance within the UK NHS Breast Screening Programme external quality assessment (EQA) scheme. METHODS: A total of 263 consecutive breast cases circulated between 2015 and 2025 were reviewed. Each case was assessed by up to 22 coordinators (expert reference panel assessors) and an average of 678 participants (all other pathologists enrolled in the EQA scheme). Cases with <80% concordance among coordinators were analysed in detail. RESULTS: Overall performance was high, with 67.4% of participants achieving 100% concordance across all circulated cases. Fifteen cases (5.7%) failed to meet the ≥80% concordance threshold. Mean diagnostic agreement in these cases was 57% (range 25%-79% among coordinators; 25%-87% among participants). Discordant cases predominantly involved atypical epithelial proliferations and papillary lesions, particularly those situated at diagnostic thresholds between established categories. Persistent challenges included distinguishing among lobular neoplasia subtypes, apocrine atypia, flat epithelial atypia, and related lesions, as well as between in situ and invasive papillary carcinoma. CONCLUSIONS: While overall concordance remains high, a small subset of biologically borderline lesions continues to generate significant diagnostic variability. These findings support further refinement of diagnostic criteria and targeted educational strategies to improve reproducibility in challenging breast lesions.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Rakha EA, Provenzano E, Kingham A, et al. Borderline breast lesions and the limits of classification: insights from the UK National Breast Screening EQA scheme. Histopathology. 2026. PMID: 42169446. doi:10.1111/his.70180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。